Lipocine to present at biotech showcase

Company management will also host meetings at lifesci partners corporate access event salt lake city , jan. 5, 2023 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a biopharmaceutical company focused on treating central nervous system ("cns") disorders by leveraging its proprietary platform to develop differentiated products, today announced that its management will present at the biotech showcase and host institutional investor and partnering meetings at this event and a corporate access event organized by lifesci partners. both in-person events will take place january 9-11, 2023, in san francisco, california.
LPCN Ratings Summary
LPCN Quant Ranking